Fulgent Genetics Inc (FLGT)
20.74
+0.10
(+0.48%)
USD |
NASDAQ |
Apr 24, 16:00
20.76
+0.02
(+0.07%)
After-Hours: 20:00
Fulgent Genetics Revenue (TTM): 289.21M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 289.21M |
| September 30, 2023 | 286.41M |
| June 30, 2023 | 307.38M |
| March 31, 2023 | 364.87M |
| December 31, 2022 | 618.97M |
| September 30, 2022 | 802.94M |
| June 30, 2022 | 925.15M |
| March 31, 2022 | 953.42M |
| December 31, 2021 | 992.58M |
| September 30, 2021 | 1.036B |
| June 30, 2021 | 909.74M |
| March 31, 2021 | 773.39M |
| December 31, 2020 | 421.71M |
| September 30, 2020 | 135.12M |
| June 30, 2020 | 43.75M |
| March 31, 2020 | 34.91M |
| Date | Value |
|---|---|
| December 31, 2019 | 32.53M |
| September 30, 2019 | 29.81M |
| June 30, 2019 | 25.09M |
| March 31, 2019 | 22.07M |
| December 31, 2018 | 21.35M |
| September 30, 2018 | 19.96M |
| June 30, 2018 | 18.84M |
| March 31, 2018 | 18.08M |
| December 31, 2017 | 18.73M |
| September 30, 2017 | 20.30M |
| June 30, 2017 | 20.81M |
| March 31, 2017 | 20.14M |
| December 31, 2016 | 18.28M |
| September 30, 2016 | 15.32M |
| June 30, 2016 | 13.22M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
25.09M
Minimum
Jun 2019
1.036B
Maximum
Sep 2021
472.78M
Average
364.87M
Median
Mar 2023
Revenue (TTM) Benchmarks
| Delcath Systems Inc | 2.065M |
| Star Equity Holdings Inc | 59.14M |
| Exact Sciences Corp | 2.500B |
| CytoSorbents Corp | 31.08M |
| Progyny Inc | 1.089B |